5433EGP
- Active ingredient
- omalizumab
- Strength
- 150mg
- Form
- vial
- Manufacturer
- novartis
- Route
- injection
Uses
Used for moderate to severe allergic asthma, chronic rhinosinusitis with nasal polyps, chronic spontaneous urticaria, and selected IgE-mediated food allergies.
Do not use if
Severe hypersensitivity to omalizumab or any component of the formulation.
Side effects
Injection-site reactions, headache, arthralgia, fatigue, and hypersensitivity reactions may occur.
Warnings
Anaphylaxis may occur even after long-term treatment. Patients should be monitored appropriately.
How it works
Anti-IgE monoclonal antibody that reduces allergic inflammatory responses by binding free IgE.
Storage
Store refrigerated at 2°C to 8°C and protect from direct sunlight.
